These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26287857)

  • 1. Chimpanzee Adenovirus Vector Ebola Vaccine--Preliminary Report.
    Ledgerwood JE; Sullivan NJ; Graham BS
    N Engl J Med; 2015 Aug; 373(8):776. PubMed ID: 26287857
    [No Abstract]   [Full Text] [Related]  

  • 2. Chimpanzee Adenovirus Vector Ebola Vaccine--Preliminary Report.
    Zhang Q; Seto D
    N Engl J Med; 2015 Aug; 373(8):775-6. PubMed ID: 26287858
    [No Abstract]   [Full Text] [Related]  

  • 3. Chimpanzee Adenovirus Vector Ebola Vaccine.
    Ledgerwood JE; DeZure AD; Stanley DA; Coates EE; Novik L; Enama ME; Berkowitz NM; Hu Z; Joshi G; Ploquin A; Sitar S; Gordon IJ; Plummer SA; Holman LA; Hendel CS; Yamshchikov G; Roman F; Nicosia A; Colloca S; Cortese R; Bailer RT; Schwartz RM; Roederer M; Mascola JR; Koup RA; Sullivan NJ; Graham BS;
    N Engl J Med; 2017 Mar; 376(10):928-938. PubMed ID: 25426834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimpanzee adenovirus vaccine protects against Zaire Ebola virus.
    Kobinger GP; Feldmann H; Zhi Y; Schumer G; Gao G; Feldmann F; Jones S; Wilson JM
    Virology; 2006 Mar; 346(2):394-401. PubMed ID: 16356525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of a recombinant adenovirus vector-based Ebola vaccine.
    Grobusch MP; Goorhuis A
    Lancet; 2017 Feb; 389(10069):578-580. PubMed ID: 28017405
    [No Abstract]   [Full Text] [Related]  

  • 6. Chimpanzee adenovirus type 3 vectored Ebola vaccine: expanding the field.
    Bavari S; Iversen PL
    Lancet Infect Dis; 2020 Jun; 20(6):636-637. PubMed ID: 32199495
    [No Abstract]   [Full Text] [Related]  

  • 7. Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus-Infected Nonhuman Primates.
    Wong G; Richardson JS; Pillet S; Racine T; Patel A; Soule G; Ennis J; Turner J; Qiu X; Kobinger GP
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S379-83. PubMed ID: 25957963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.
    Milligan ID; Gibani MM; Sewell R; Clutterbuck EA; Campbell D; Plested E; Nuthall E; Voysey M; Silva-Reyes L; McElrath MJ; De Rosa SC; Frahm N; Cohen KW; Shukarev G; Orzabal N; van Duijnhoven W; Truyers C; Bachmayer N; Splinter D; Samy N; Pau MG; Schuitemaker H; Luhn K; Callendret B; Van Hoof J; Douoguih M; Ewer K; Angus B; Pollard AJ; Snape MD
    JAMA; 2016 Apr; 315(15):1610-23. PubMed ID: 27092831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-vectored Ebola vaccines.
    Gilbert SC
    Expert Rev Vaccines; 2015; 14(10):1347-57. PubMed ID: 26289977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of novel vaccine vectors: Chimpanzee adenoviral vectors.
    Guo J; Mondal M; Zhou D
    Hum Vaccin Immunother; 2018 Jul; 14(7):1679-1685. PubMed ID: 29300685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine.
    Zhou Y; Sullivan NJ
    Curr Opin Immunol; 2015 Aug; 35():131-6. PubMed ID: 26247875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults.
    Ledgerwood JE; Costner P; Desai N; Holman L; Enama ME; Yamshchikov G; Mulangu S; Hu Z; Andrews CA; Sheets RA; Koup RA; Roederer M; Bailer R; Mascola JR; Pau MG; Sullivan NJ; Goudsmit J; Nabel GJ; Graham BS;
    Vaccine; 2010 Dec; 29(2):304-13. PubMed ID: 21034824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete nucleotide sequences and genome organization of four chimpanzee adenoviruses.
    Roy S; Gao G; Clawson DS; Vandenberghe LH; Farina SF; Wilson JM
    Virology; 2004 Jul; 324(2):361-72. PubMed ID: 15207622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.
    Zhu FC; Wurie AH; Hou LH; Liang Q; Li YH; Russell JB; Wu SP; Li JX; Hu YM; Guo Q; Xu WB; Wurie AR; Wang WJ; Zhang Z; Yin WJ; Ghazzawi M; Zhang X; Duan L; Wang JZ; Chen W
    Lancet; 2017 Feb; 389(10069):621-628. PubMed ID: 28017399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebola vaccine success.
    Mullard A
    Nat Rev Drug Discov; 2017 Feb; 16(2):77. PubMed ID: 28148944
    [No Abstract]   [Full Text] [Related]  

  • 16. Ebola "Ring" Vaccine Trial Was Ethically Innovative.
    Haire BG; Folayan MO
    Am J Public Health; 2016 Sep; 106(9):e1. PubMed ID: 27509285
    [No Abstract]   [Full Text] [Related]  

  • 17. [First success with Ebola vaccine].
    Mut
    MMW Fortschr Med; 2015 Aug; 157(14):6. PubMed ID: 26289857
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimization of Prime-Boost Vaccination Strategies Against Mouse-Adapted Ebolavirus in a Short-Term Protection Study.
    Aviles J; Bello A; Wong G; Fausther-Bovendo H; Qiu X; Kobinger G
    J Infect Dis; 2015 Oct; 212 Suppl 2():S389-97. PubMed ID: 26038398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola: The great ape gamble.
    Willyard C
    Nature; 2017 Mar; 543(7647):S56-S57. PubMed ID: 28355186
    [No Abstract]   [Full Text] [Related]  

  • 20. Respiratory vaccine shows promise.
    Can Nurse; 2014 Dec; 110(9):8. PubMed ID: 25751971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.